These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21930609)

  • 1. B-cell responses during primary and secondary dengue virus infections in humans.
    Mathew A; West K; Kalayanarooj S; Gibbons RV; Srikiatkhachorn A; Green S; Libraty D; Jaiswal S; Rothman AL
    J Infect Dis; 2011 Nov; 204(10):1514-22. PubMed ID: 21930609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
    Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
    J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay.
    Hadjilaou A; Green AM; Coloma J; Harris E
    J Immunol; 2015 Oct; 195(7):3490-6. PubMed ID: 26320246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary and Secondary Dengue Virus Infections Elicit Similar Memory B-Cell Responses, but Breadth to Other Serotypes and Cross-Reactivity to Zika Virus Is Higher in Secondary Dengue.
    Andrade P; Narvekar P; Montoya M; Michlmayr D; Balmaseda A; Coloma J; Harris E
    J Infect Dis; 2020 Jul; 222(4):590-600. PubMed ID: 32193549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.
    Beltramello M; Williams KL; Simmons CP; Macagno A; Simonelli L; Quyen NT; Sukupolvi-Petty S; Navarro-Sanchez E; Young PR; de Silva AM; Rey FA; Varani L; Whitehead SS; Diamond MS; Harris E; Lanzavecchia A; Sallusto F
    Cell Host Microbe; 2010 Sep; 8(3):271-83. PubMed ID: 20833378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
    Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
    J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells.
    Friberg H; Jaiswal S; West K; O'Ketch M; Rothman AL; Mathew A
    Viral Immunol; 2012 Oct; 25(5):348-59. PubMed ID: 22934599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans.
    Zompi S; Montoya M; Pohl MO; Balmaseda A; Harris E
    PLoS Negl Trop Dis; 2012; 6(3):e1568. PubMed ID: 22448292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the human serum antibody response to secondary dengue virus infections.
    Patel B; Longo P; Miley MJ; Montoya M; Harris E; de Silva AM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005554. PubMed ID: 28505154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
    Gelanew T; Hunsperger E
    Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.
    Zidane N; Dussart P; Bremand L; Bedouelle H
    BMC Infect Dis; 2013 Jul; 13():302. PubMed ID: 23815496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
    Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A
    J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses.
    Malavige GN; McGowan S; Atukorale V; Salimi M; Peelawatta M; Fernando N; Jayaratne SD; Ogg G
    Clin Exp Immunol; 2012 May; 168(2):215-23. PubMed ID: 22471283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of DENV Serotypes during Early Infection.
    Lai SC; Huang YY; Shu PY; Chang SF; Hsieh PS; Wey JJ; Tsai MH; Ben RJ; Hsu YM; Fang YC; Hsiao ML; Lin CC
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 30971466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
    Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
    J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in-depth analysis of original antigenic sin in dengue virus infection.
    Midgley CM; Bajwa-Joseph M; Vasanawathana S; Limpitikul W; Wills B; Flanagan A; Waiyaiya E; Tran HB; Cowper AE; Chotiyarnwong P; Grimes JM; Yoksan S; Malasit P; Simmons CP; Mongkolsapaya J; Screaton GR
    J Virol; 2011 Jan; 85(1):410-21. PubMed ID: 20980526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.
    Masrinoul P; Omokoko MD; Pambudi S; Ikuta K; Kurosu T
    Viral Immunol; 2013 Aug; 26(4):250-8. PubMed ID: 23941673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.
    Woda M; Friberg H; Currier JR; Srikiatkhachorn A; Macareo LR; Green S; Jarman RG; Rothman AL; Mathew A
    J Infect Dis; 2016 Oct; 214(7):1001-9. PubMed ID: 27443614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.